NEW YORK (Feb. 2, 2005) -- The Center of Excellence for Lymphoma and Myeloma at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the only medical center in the nation to currently offer a chemotherapy cocktail with the next-generation immuno-modulatory research drug Revlimid (lenalidomide), as part of a clinical trial for patients with newly diagnosed multiple myeloma. Results of the single-center Phase II clinical trial are anticipated to show improved complete remission rate and response time, and decreased toxicity -- compared to the standard treatment.
The discovery by a Cornell University and Weill Cornell Medical College scientist that poly (ADP-ribose) polymerase-1 (PARP-1) plays a pivotal role in gene transcription could open doors to new therapies for cancer and neurological disease, and even hints at connections between the foods we eat and gene expression within our cells.
Working conditions in the U.S. meat and poultry industry are so hazardous and the tactics that employers use to prevent workers from organizing so threatening that the industry consistently violates basic human rights.
NEW YORK (February 1, 2005) -- To better address the acute medical needs of the growing number of adults aged 75 and older, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a Geriatric Emergency Medicine Fellowship, a first-of-its-kind program for physicians who have completed their residency training in emergency medicine.
The Qur'an, Islam's sacred text, offers Muslim women the same rights as men, according to a new book, Woman's Identity and the Qur'an: A New Reading, by Nimat Hafez Barazangi, a research fellow in Cornell's Feminist, Gender and Sexuality Studies Program.
Jessica Govea Thorbourne, a labor educator with Cornell's School of Industrial and Labor Relations in New York City and a founding organizer of Cesar Chavez's United Farm Workers (UFW) Union, died Jan. 23, 2005.
NEW YORK (January 31, 2005) -- A new Cornell study found that screening for osteoporosis with bone density scans was associated with 36% fewer hip fractures over six years compared with usual medical care. The study will be published in the February 1 issue of the Annals of Internal Medicine.
It's a constitutional given that the nine justices of the nation's highest court are appointed for life. But Cornell law professor Roger Cramton is asking: Should they be?
The root systems of trees are known to be major storage banks for carbon dioxide (CO2), a major greenhouse gas implicated in global warming. Figuring out exactly how much of the carbon is held by these roots has been complicated by the difficulty of predicting the mass of the underground root systems. But now Cornell University professor of plant biology Karl Niklas and a colleague have proposed a mathematical sealing model that is able to predict very accurately size-dependent relationships for small- and intermediate-size plants, from the very smallest herbaceous plants to the world's tallest trees. In doing so, the model can determine the mass of root systems. (January 31, 2005)
Stephen J. "Doc" Roberts, who as an undergraduate, led Cornell University's polo team to its first national championship and then, as a veterinarian, coached the university's polo team to eight national championships, died in Bath, N.Y., Jan. 21, 2005, of heart failure. He was 89. Roberts coached the Cornell polo team between 1947 and 1972, and his teams participated in 14 national championships, winning eight in 25 years. (The winning years: 1955, '56, '59, '61, '62, '63 and '66.) He was the captain of the team when he was an undergraduate. (January 27, 2005)
As part of its American debut tour, the Peking University Performing Arts Troupe will present a free performance at Cornell University, Wednesday, Feb. 2, at 7:30 p.m. in the Schwartz Center for the Performing Arts' Kiplinger Theatre. General admission will be on a first-come, first-served basis. The troupe, led by Xu Zhihong, president of Peking University, is in the midst of an 11-day tour, with stops at five universities, including Cornell, Columbia and Yale. (January 27, 2005)
Two Cornell University researchers have found a pathway that is critical for the flu virus to enter and infect a cell. The discovery could lead to the development of antiviral medications and vaccines that would target all influenza viruses. The newly discovered pathway occurs after the virus attaches to a cell. The next stage of infection, the Cornell researchers say, involves an unknown co-receptor that allows the virus to infect the cell. (January 26, 2005)
